Relapsed/Refractory Aggressive B-Cell Lymphoma
2 clinical trials · Condition
◉ Watch Relapsed/Refractory Aggressive B-Cell Lymphoma
| Record | Firm | Date |
|---|---|---|
| Clinical Study of SYS6055 Injection in Participants With Relapsed/Refractory Aggressive B-Cell Lymphoma (NCT07476066) | Beijing Kangchuanglian Biopharmaceutical Technology Research Co., Ltd | 2026-03-15 |
| A Study to Learn How Safe and Tolerable Odronextamab and Cemiplimab Are in Adult Patients With B-cell Malignancies (NCT02651662) | Regeneron Pharmaceuticals | 2016-01-11 |
Track Relapsed/Refractory Aggressive B-Cell Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.